Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 3, 1999, Pages 295-304

  Barentsz, Jelle O ^a   Engelbrecht, Marc ^a   Jager, Gerrit J ^a   Witjes, J Alfred ^a   De LaRosette, Jean ^a   Van Der Sanden, Boudewijn P J ^a   Huisman, Henk Jan ^a   Heerschap, Arend ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Magnetic resonance; Prostate cancer; Urinary bladder

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM CHELATE;

ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER STAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; GRANULATION TISSUE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; SEMINAL VESICLE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; SIGNAL PROCESSING, COMPUTER-ASSISTED; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0032851742     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199909)10:3<295::AID-JMRI10>3.0.CO;2-Z     Document Type: Article

References (41)

1. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
2. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;8:4-6.
3. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 1994;73:678-687.
4. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 1994;74:762-766.
5. Kirby RS. Pre-treatment staging of prostate cancer: recent advances and future prospects. Prostate Cancer Prostatic Dis 1997;1:2-10.
6. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer 1992;84:1875-1887.
7. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantification and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-761.
8. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool: review. J Clin Oncol 1995;13:765-782.
9. Pass TJ, Bluemke DA, Siegelmann SS. Tumorangiogenesis: tutorial on implications for imaging. Radiology 1997;203:593-600.
10. Rubin MA, Buyyounouski M, Bagiella, et al. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathological stage, and clinical outcome. Urology 1999;53:542-547.
11. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990;174:491-494.
12. Preziosi P, Di Giambattista G, Di Renzi P, et al. Endorectal-coil MRI with dynamic subtraction technique in prostate cancer: evaluation of tumoral tissue behaviour with the time/signal intensity curve analysis. Radiology 1998;206:259.
13. Schiebler M, Schnall MD, Pollack HW, et al. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 1993;189:339-352.
14. Boetes C, Barentsz JO, Mus RD, van der Sluis RF, van Eming LJThO, Hendriks JHCL, Holland R. MR characterization of suspicious breast lesions with gadolinium-enhanced Turbo-FLASH subtraction technique. Radiology 1994;193:777-781.
15. Barentsz JO, Jager GJ, Witjes F, et al. Dynamic subtraction Turbo-FLASH MR imaging in staging urinary bladder cancer after transurethral resection and chemotherapy. Radiology 1994;193: 167.
16. Barentsz JO, Ruijs SHJ, Strijk SP. The role of MR imaging in carcinoma of the urinary bladder. AJR 1993;160:937-947.
17. Jager GJ, Ruijter ETG, vd Ka CA, et al. Dynamic Turbo-FLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathology. Radiology 1997;203:645-652.
18. Van der Woude HJ, Verstraete KL, Hogendoorn PCW. Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR-imaging contribute to the characterization? Radiology 1998;208: 821-828.
19. Van der Sanden B, Rozijn TH, Rijken PFJW, et al. Gd-DTPA-uptake rates are linearly related to the perfused microvessel density and surface-area in 9L-glioma in rat brain. Magma 1998;6:58 (abstract).
20. Degani H, Gusis V, Weinstein D, Fields S, Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nature Med 1997;7:780-782.
21. Delorme S, Knopp MV. Non-invasive vascular imaging: assessing tumor vascularity. In: Abdominal and peripheral vessels. ECR 99 Syllabus. 1999:91-101.
22. Jewett HJ. Cancer of the bladder. Cancer 1973;32:1072-1075.
23. Doringer E, Joos H, Forstner R, Schmoller H. MRI of bladder carcinoma: tumor staging and gadolinium contrast behaviour. Fortschr Rontgenstr 1991;154:357-363.
24. Sohn M, Neuerburg JM, Teufl F, Bohndorf K. Gadolinium-enhanced magnetic resonance imaging in the staging of urinary bladder neoplasms. Urol Int 1990;45:142-147.
25. Nicolas V, Spielmann R, Maas R, Bressel M, Wagner B, Porst H, Bucheler E. The diagnostic value of MRI and gadolinium-DTPA compared with CT for the diagnosis of bladder tumors. Fortschr Rontgenstr 1990;153:197-203.
26. Sparenberg A, Hamm B, Hammerer P, Samberger V, Wolf KJ. The diagnosis of bladder carcinomas by NMR tomography: an Improvement with Gd-DTPA? Fortschr Rontgenstr 1991;155:117-122.
27. Tachibana M, Baba S, Deguchi N, et al. Efficacy of gadolinium-diethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder: a comparative study with computerized tomography and transurethral ultrasonography. J Urol 1991;145: 1169-1173.
28. Kim B, Semelka RC, Ascher SM, Chalpin DB, Carrol PR, Hricak H. Bladder tumor staging: comparison of contrast enhanced CT, T1- and T2-weighted MR imaging, dynamic Gadolinium-enhanced imaging, and late Gadolinium-enhanced imaging. Radiology 1994;193:239-245.
29. Neuerburg JM, Bohndorf K, Sohn M, Teufl F, Guenther RW, Daus HJ. Urinary bladder neoplasms: evaluation with contrast-enhanced MR imaging. Radiology 1989;172:739-743.
30. McGinnis DE, Rifkin MD, Gomella LG. New MR imaging techniques for staging bladder cancer: endorectal coil and gadolinium image enhancement. J Urol 1992;147:402A (abstract).
31. Barentsz JO, Jager GJ, van Vierzen PBJ, et al. Staging urinary bladder cancer after transurethral biopsy: the value of fast dynamic contrast-enhanced MR imaging. Radiology 1996;201:185-193.
32. Barentsz JO, Berger-Hartog O, Witjes JA, et al. Fast dynamic contrast enhanced MRI in the evaluation of chemotherapy in advanced bladder cancer. Radiology 1998;207:791-797.
33. Denis LJ, Murphy GP, Schroeder FH. Report of the consensus workshop on screening and global strategy for prostate cancer. Cancer 1995;75:1187-1207.
34. Perrotti M, Kaufman RP Jr, Jennings TA, et al. Endo-rectal coil magnetic resonance imaging in clinically localized prostet cancer: is it accurate? J Urol 1996;156:106-109.
35. Bostwick DG, Quian J, Bergstralh EJ, et al. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 1996;155:1361-1367.
36. Quinn SF, Franzini DA, Demlow TA, et al. MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens. Radiology 1994;190:323-327.
37. Mirowitz SA, Brown JJ, Heiken JP. Evaluation of the prostate and prostatic carcinoma with Gd-enhanced endorectal coil MR imaging. Radiology 1993;186:153-157.
38. Sommer FG, Nghiem HV, Herfkens R, McNeal JE. Gd-enhanced MRI of the abnormal prostate. Magn Reson Imaging 1993;11:841-948.
39. Brown G, Macvicar DA, Ayton V, Husband JE. The role of intravenous contrast enhancement in MRI of prostatic carcinoma. Clin Radiol 1995;50:601-606.
40. Yoshizako T, Sugimura K, Kaji Y, Moriyama M, Wada A. Prostate and prostatic carcinoma: comparison of Gd-enhanced MR images and histopathologic findings. Nipon-Igaku-Hoshasen-Gakkai-Zasshi 1995;55:545-549.
41. Huch Boni RA, Boner JA, Lutolf UM, et al. Contrast-enhanced endorectal coil MRI in local staging of prostate carcinoma. J Comput Assist Tomogr 1995;19:232-237.